Related Experiment Video
Updated: May 7, 2026
Intra-lymph Node Injection of Biodegradable Polymer Particles
Published on: January 2, 2014
Polymer-mRNA complexes for monocyte-trafficked, lymph node-targeted cancer vaccination
Qiongzhe Ren1, Xiaofei Zhao1, Lili Zhou2
1Biomedical Polymers Laboratory, College of Chemistry, Chemical Engineering and Materials Science, Soochow University, Suzhou, P. R. China.
Abstract:
Lymph nodes are the primary sites where adaptive immunity is initiated, yet most messenger RNA cancer vaccines reach them inefficiently and instead accumulate in organs such as the liver, limiting therapeutic potency and increasing systemic toxicity. Here we developed a transferrin receptor-associating polyplex formed by electrostatic complexation of mRNA with low-molecular-weight polyethylenimine that had been chemically modified with cyclic disulfide monomers to enhance nucleic acid binding stability, enable thiol-based transferrin receptor engagement and reduce off-target liver uptake. After subcutaneous administration, these polyplexes activated innate immunity, rapidly recruited monocytes with high transferrin receptor expression and bound these cells through cyclic disulfide-mediated interactions. Monocytes then trafficked the vaccine to draining lymph nodes, where mRNA translation and antigen presentation occurred. Delivery of ovalbumin and interleukin 12 mRNA elicited strong antigen-specific cytotoxic T cell responses and inhibited melanoma progression and metastatic disease. Studies using Survivin and human papillomavirus antigens in distinct tumour models demonstrated broad applicability. This monocyte-driven lymph node-targeting strategy enables potent and selective delivery of mRNA cancer vaccines.
Insights
Researchers developed a novel mRNA cancer vaccine delivery system that targets monocytes to enhance lymph node accumulation. This strategy improves therapeutic potency and reduces toxicity by optimizing messenger RNA delivery for potent cancer immunity.
Area of Science:
- Biotechnology
- Immunology
- Oncology
Background:
- Lymph nodes are crucial for adaptive immunity initiation.
- Current messenger RNA (mRNA) cancer vaccines show inefficient lymph node delivery, leading to liver accumulation, reduced efficacy, and increased toxicity.
Purpose of the Study:
- To develop a novel polyplex system for enhanced lymph node targeting of mRNA cancer vaccines.
- To improve the stability and targeting of mRNA vaccines via transferrin receptor engagement.
- To reduce off-target accumulation in the liver and minimize systemic toxicity.
Main Methods:
- Developed a transferrin receptor-associating polyplex using modified low-molecular-weight polyethylenimine and mRNA.
- Utilized cyclic disulfide monomers for enhanced nucleic acid binding and thiol-based transferrin receptor engagement.
- Administered polyplexes subcutaneously and tracked monocyte recruitment and trafficking to lymph nodes.
Main Results:
- Polyplexes activated innate immunity and recruited monocytes expressing high transferrin receptor levels.
- Monocytes facilitated vaccine transport to draining lymph nodes, enabling mRNA translation and antigen presentation.
- Delivery of ovalbumin and interleukin 12 mRNA induced strong cytotoxic T cell responses, inhibiting melanoma progression and metastasis.
Conclusions:
- A monocyte-driven lymph node-targeting strategy effectively delivers mRNA cancer vaccines.
- The developed polyplex system enhances vaccine potency and selectivity.
- Demonstrated broad applicability using different antigens and tumor models, including Survivin and human papillomavirus antigens.
More Related Videos
Related Concept Videos
01:30Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers